Your browser doesn't support javascript.
loading
Corrigendum: Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity.
Sam, Johannes; Colombetti, Sara; Fauti, Tanja; Roller, Andreas; Biehl, Marlene; Fahrni, Linda; Nicolini, Valeria; Perro, Mario; Nayak, Tapan; Bommer, Esther; Schoenle, Anne; Karagianni, Maria; Le Clech, Marine; Steinhoff, Nathalie; Klein, Christian; Umaña, Pablo; Bacac, Marina.
Afiliación
  • Sam J; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Colombetti S; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Fauti T; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Roller A; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland.
  • Biehl M; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Fahrni L; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Nicolini V; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Perro M; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Nayak T; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland.
  • Bommer E; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Schoenle A; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Karagianni M; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Le Clech M; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Steinhoff N; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Klein C; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Umaña P; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
  • Bacac M; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland.
Front Oncol ; 11: 650149, 2021.
Article en En | MEDLINE | ID: mdl-33614518
ABSTRACT
[This corrects the article .].
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: Suiza